FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885996817> ?p ?o ?g. }

• W2885996817 endingPage "746" @default.
• W2885996817 startingPage "737" @default.
• W2885996817 abstract "Objectives: To evaluate the real-world safety and effectiveness of etanercept (ETN) in Japanese patients with rheumatoid arthritis. Methods: This postmarketing surveillance study (NCT00503139) assessed the safety and effectiveness of ETN treatment over 3 and 2 years (from June 2007 to September 2011), respectively. Safety was evaluated by occurrence and seriousness of adverse drug reactions (ADRs), and of adverse events (AEs) for malignancies. Effectiveness was assessed using the Disease Activity Score in 28 joints based on the erythrocyte sedimentation rate (ESR) with four variables (swollen and tender joint counts, ESR, and patient global assessment; DAS28-4/ESR). Treatment was considered effective if patients had a good/moderate response by the European League Against Rheumatism response criteria. Results: ADRs occurred in 256/675 (37.9%) patients, the most common being injection site reactions (4.4%) and nasopharyngitis (3.3%). Serious ADRs occurred in 60/675 (8.9%) patients, the most frequent being pneumonia (1.2%). The incident rate of malignancies (AEs) was 1.06 per 100 patient-years. Mean baseline DAS28-4/ESR for the 581 patients included in effectiveness analysis was 5.42, which decreased to 3.32 at 2 years. Eighty-two percent of patients achieved a moderate/good response at 2 years. Conclusion: Long-term ETN treatment safety and effectiveness were sustained over 3 and 2 years, respectively." @default.
• W2885996817 created "2018-08-22" @default.
• W2885996817 creator A5004553440 @default.
• W2885996817 creator A5034961766 @default.
• W2885996817 creator A5041646818 @default.
• W2885996817 creator A5053803963 @default.
• W2885996817 creator A5063192431 @default.
• W2885996817 creator A5068829670 @default.
• W2885996817 creator A5070084831 @default.
• W2885996817 creator A5075892667 @default.
• W2885996817 creator A5083044716 @default.
• W2885996817 creator A5088827025 @default.
• W2885996817 date "2018-09-20" @default.
• W2885996817 modified "2023-09-30" @default.
• W2885996817 title "Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance" @default.
• W2885996817 cites W1944740377 @default.
• W2885996817 cites W1982176411 @default.
• W2885996817 cites W1993923138 @default.
• W2885996817 cites W1996389186 @default.
• W2885996817 cites W2004096888 @default.
• W2885996817 cites W2017860861 @default.
• W2885996817 cites W2028921790 @default.
• W2885996817 cites W2039110250 @default.
• W2885996817 cites W2069826111 @default.
• W2885996817 cites W2071099746 @default.
• W2885996817 cites W2088438184 @default.
• W2885996817 cites W2088839692 @default.
• W2885996817 cites W2111153776 @default.
• W2885996817 cites W2117335168 @default.
• W2885996817 cites W2120393706 @default.
• W2885996817 cites W2128952811 @default.
• W2885996817 cites W2142004396 @default.
• W2885996817 cites W2155402987 @default.
• W2885996817 cites W2156552533 @default.
• W2885996817 cites W2156712409 @default.
• W2885996817 cites W2156996668 @default.
• W2885996817 cites W2163184895 @default.
• W2885996817 cites W2169855580 @default.
• W2885996817 cites W221923405 @default.
• W2885996817 cites W4249959283 @default.
• W2885996817 cites W4252060375 @default.
• W2885996817 cites W4252774069 @default.
• W2885996817 cites W4252809665 @default.
• W2885996817 doi "https://doi.org/10.1080/14397595.2018.1510759" @default.
• W2885996817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30092161" @default.
• W2885996817 hasPublicationYear "2018" @default.
• W2885996817 type Work @default.
• W2885996817 sameAs 2885996817 @default.
• W2885996817 citedByCount "5" @default.
• W2885996817 countsByYear W28859968172020 @default.
• W2885996817 countsByYear W28859968172021 @default.
• W2885996817 countsByYear W28859968172022 @default.
• W2885996817 countsByYear W28859968172023 @default.
• W2885996817 crossrefType "journal-article" @default.
• W2885996817 hasAuthorship W2885996817A5004553440 @default.
• W2885996817 hasAuthorship W2885996817A5034961766 @default.
• W2885996817 hasAuthorship W2885996817A5041646818 @default.
• W2885996817 hasAuthorship W2885996817A5053803963 @default.
• W2885996817 hasAuthorship W2885996817A5063192431 @default.
• W2885996817 hasAuthorship W2885996817A5068829670 @default.
• W2885996817 hasAuthorship W2885996817A5070084831 @default.
• W2885996817 hasAuthorship W2885996817A5075892667 @default.
• W2885996817 hasAuthorship W2885996817A5083044716 @default.
• W2885996817 hasAuthorship W2885996817A5088827025 @default.
• W2885996817 hasBestOaLocation W28859968171 @default.
• W2885996817 hasConcept C126322002 @default.
• W2885996817 hasConcept C197636746 @default.
• W2885996817 hasConcept C197934379 @default.
• W2885996817 hasConcept C2777226972 @default.
• W2885996817 hasConcept C2777489490 @default.
• W2885996817 hasConcept C2777575956 @default.
• W2885996817 hasConcept C2778143017 @default.
• W2885996817 hasConcept C71924100 @default.
• W2885996817 hasConceptScore W2885996817C126322002 @default.
• W2885996817 hasConceptScore W2885996817C197636746 @default.
• W2885996817 hasConceptScore W2885996817C197934379 @default.
• W2885996817 hasConceptScore W2885996817C2777226972 @default.
• W2885996817 hasConceptScore W2885996817C2777489490 @default.
• W2885996817 hasConceptScore W2885996817C2777575956 @default.
• W2885996817 hasConceptScore W2885996817C2778143017 @default.
• W2885996817 hasConceptScore W2885996817C71924100 @default.
• W2885996817 hasFunder F4320307784 @default.
• W2885996817 hasIssue "5" @default.
• W2885996817 hasLocation W28859968171 @default.
• W2885996817 hasLocation W28859968172 @default.
• W2885996817 hasOpenAccess W2885996817 @default.
• W2885996817 hasPrimaryLocation W28859968171 @default.
• W2885996817 hasRelatedWork W2125935509 @default.
• W2885996817 hasRelatedWork W2352829214 @default.
• W2885996817 hasRelatedWork W2369698039 @default.
• W2885996817 hasRelatedWork W2397817360 @default.
• W2885996817 hasRelatedWork W2415337019 @default.
• W2885996817 hasRelatedWork W2460286564 @default.
• W2885996817 hasRelatedWork W2756161074 @default.
• W2885996817 hasRelatedWork W2885996817 @default.
• W2885996817 hasRelatedWork W3014759176 @default.
• W2885996817 hasRelatedWork W3183999488 @default.
• W2885996817 hasVolume "29" @default.

• next